Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2022; 68(2): 68-73


I.N. Mikheytseva1, V.R. Yurevich2

  1. Filatov Institute of Eye Diseases and Tissue Therapy of NAMS of Ukraine, Odesa, Ukraine
  2. Danylo Halytsky Lviv National Medical Unibersity, Ukraine


During experimental glaucoma with diabetes in rabbits, in the filtering tissues of the eye, a state of oxidative stress is formed manifested by a significant decrease in the activity of antioxidant enzymes and the accumulation of products of free radical oxidation of lipids and proteins. Administration of a lipid-soluble form of vitamin B1 benfotiamine effectively reduced the manifestations of oxidative stress in the tissues of the anterior chamber of the animal eyes. This biologically active substance increased antioxidant capacity in tissues by activating antiradical protection enzymes: superoxide dismutase activity increased by 51%, catalase by 36% and glutathione peroxidase by 45% compared to the untreated animals. In addition, the processes of lipid peroxidation and oxidative destruction of protein molecules were decreased under the influence of benfotiamine. The level of malondialdehyde (MDA) was reduced by 47%, and the marker of oxidative damage to proteins of CO-groups by 35% relative to the untreated group. The results obtained may be a basis for further studies of the pharmacological substance benfotiamine in the clinic of glaucoma accompanied by diabetes, which will expand the arsenal of pathogenetically sound therapy of this serious disease.

Keywords: benfotiamine; oxidative stress; glaucoma; diabetes; eye tissue.


  1. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res. 2006;612(2):105-14. CrossRef PubMed
  2. Zanon-Moreno V, Marco-Ventura P, Lleo-Perez A, et al. Oxidative stress in primary open-angle glaucoma. J Glaucoma. 2008;17(4):263-8. CrossRef PubMed
  3. Ramdas WD, Wolfs RCW, Kiefte-de Jong JC, et al. Nutrient intake and risk of open-angle glaucoma: the Rotterdam study. Eur J Epidemiol. 2012;27:385-93. CrossRef PubMed PubMedCentral
  4. Thornalley P. The potential role of thiamine (vitamin B1) in diabetic complications. Current Diabet Rev. 2005;1(3):287-98. CrossRef PubMed
  5. Gleiter GH, Schreeb KH, Freudenthaler S. Comparative bioavailability of two vitamin B1 preparations:benfotiamine and thiamin mononitrate. In: Gries FA, Federlin K, eds. Benfotiamine in the therapy of polyneuropathy. New York: Georg Thieme Verlag. 1998;29-33.
  6. Harisa GI. Benfotiamine enhances antioxidant defenses and protects against cisplatin-induced DNA damage in nephrotoxic rats. J Biochem Mol Toxicol. 2013;27: 398-405. CrossRef PubMed
  7. Mikheytseva IN, Yurevich VR. The effect of the fat-soluble form of vitamin B1 on the carbonil metabolites content in the eye tissues of rabbits with experimental glaucoma, aggravated by diabetes. Physiol J. 2020;66(2-3):44-50. CrossRef
  8. Bozic I, Savic D, Stevanovic I, Pekovic S, Nedeljkovic N, Lavrnja I. Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells. Front Cell Neurosci. 2015;9:351. CrossRef PubMed PubMedCentral
  9. Mikhetseva IN. Patogeneticheskoe znachenie endotelial'noj disfunkcii pri pervichnoj glaukome. Achiev Biol Med. 2009;14(2):17-20.
  10. Balakumar P, Sharma R, Singh M. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. Pharmacol Res 2008;58:356-63. CrossRef PubMed
  11. Yurevich VR. Aktivnost' antioksidantnyh fermentov v tkanyah ugla perednej kamery i kamernoj vlage pri eksperimental'noj gipertenzii i streptozotocinovom diabete. Harkivs'ka Hirurgichna Shkola. 2015, 6(75): 64-70.
  12. Yurevich VR. Vliyanie oftal'mogipertenzii na uroven' produktov perekisnogo okisleniya lipidov v tkanyah perednego otdela glaza pri eksperimental'nom diabete. Oftal'mol Zh. 2015;4(38-43).
  13. Wang J, Wan R, Mo Y. Creating a long-term diabetic rabbit model. Exp Diabetes Res. 2010;6:1-10. CrossRef PubMed PubMedCentral
  14. Zhu M, Cai F. Development of experimental chronic intraocular hypertension in the rabbit. Australian and New Zeland J Ophthalmol. 1992;20:225-34. CrossRef PubMed
  15. Orekhovich VN. Sovremennye metody v biohimii. M.: Medicina. 1977.
  16. Fields R, Dixon H. Micro method for determination of reactive carbonyl groups in proteins and peptides,using 2,4-dinitrophenylhydrazine. Biochem J. 1971;121:587-9. CrossRef PubMed PubMedCentral
  17. Novy'e metody biokhimicheskogo analiza. Leningrad Univ. 1991.
  18. Bergmeyer HU. Methoden der enzymatischen analyse. Herausgegeben von HU Bergmeyer, Berlin. 1986.
  19. Voronych-Semchenko NM, Guranych TV. Changes of processes of free radical oxidation of lipids and proteins, antioxidant defense in rats with hypofunction of thyroid gland on the background of iodine and copper deficit. Physiol J. 2014;60(4):30-9.
  20. Davanand C, Vegi P. Protein carbonyl content as a stable oxidative stress marker in type II diabetes. Int J Biol Med Res. 2012;3:2362-65.
  21. Davy'dov V, Bozhkov A. Karbonil'ny'j stress kak nespeczificheskij faktor patogeneza. Zh NAMN Ukr, 2014;20(1):25-34.
  22. Schmid, U., H. Stopper, A. Heidland and N. Schupp,. Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro. Diabetes Metab Res Rev. 2008;24:371-7. CrossRef PubMed
  23. Bushra Hasan Marouf, Tavga Ahmed Aziz, Munaf Hashim Zalzala, Saad Abdulrahman Hussain. Free radical scavenging activity of benfotiamine in nitrite-induced hemoglobin oxidation and membrane fragility models. J Pharm Biomed Sci. 2010;1(1):13-8.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.